Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.

Saved in:
Bibliographic Details
Title: Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.
Authors: Nickols NG; Radiation Oncology Service, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Goetz MB; Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Graber CJ; Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Bhattacharya D; Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Soo Hoo G; Division of Pulmonary and Critical Care, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Might M; Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, USA., Goldstein DB; Institute of Genomic Medicine, Columbia University Irving Medical Center, New York, USA., Wang X; Institute of Genomic Medicine, Columbia University Irving Medical Center, New York, USA., Ramoni R; Office of Research and Development, Veterans Health Administration, Washington, D.C., USA., Myrie K; Office of Research and Development, Veterans Health Administration, Washington, D.C., USA., Tran S; Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Ghayouri L; Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Tsai S; Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Geelhoed M; Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA., Makarov D; Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA., Becker DJ; Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA.; Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, USA., Tsay JC; Division of Pulmonary and Critical Care, VA New York Harbor Healthcare System, New York, USA., Diamond M; Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA., George A; Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA., Al-Ajam M; Division of Pulmonary and Critical Care, VA New York Harbor Healthcare System, New York, USA., Belligund P; Division of Pulmonary and Critical Care, VA New York Harbor Healthcare System, New York, USA., Montgomery RB; Division of Hematology-Oncology, VA Puget Sound Healthcare System, Seattle, USA., Mostaghel EA; Geriatric Research Education and Clinical Care (GRECC), VA Puget Sound Health Care System, Seattle, USA., Sulpizio C; Division of Hematology-Oncology, VA Puget Sound Healthcare System, Seattle, USA., Mi Z; VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA., Dematt E; VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA., Tadalan J; VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA., Norman LE; VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA., Briones D; VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA., Clise CE; VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA., Taylor ZW; VA Cooperative Research Pharmacy Coordinating Center, Albuquerque, NM, USA., Huminik JR; VA Cooperative Research Pharmacy Coordinating Center, Albuquerque, NM, USA., Biswas K; VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA., Rettig MB; Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA. matthew.rettig@va.gov.
Source: Trials [Trials] 2021 Jul 05; Vol. 22 (1), pp. 431. Date of Electronic Publication: 2021 Jul 05.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1745-6215
DOI:10.1186/s13063-021-05389-0